Fingerprint
Dive into the research topics where Alexander Krauthammer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Gastric ghrelin is reduced in children with Helicobacter pylori gastritis compared to children without Helicobacter pylori
Krauthammer, A., Berger, T. D., Nachum, N., Granot, M., Barshack, I. & Weiss, B., Jan 2026, In: Journal of Pediatric Gastroenterology and Nutrition. 82, 1, p. 18-23 6 p.Research output: Contribution to journal › Article › peer-review
-
Elderly-Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns
Granot, M., Kopylov, U., Talmor, Y., Nachum, N., Krauthammer, A., Berger, T., Abitbol, C. M., Dotan, A., Borenstein, E., Ben-Horin, S., Weiss, B. & Haberman, Y., Nov 2025, In: United European Gastroenterology Journal. 13, 9, p. 1754-1764 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Fecal content from IBD patients causes more severe epithelial damage than fecal content from healthy donors, which can be moderated by supplementation of metabolites cocktail
Abbas-Egbariya, H., Elwahidi, L., Braun, T., Granot, M., Krauthammer, A., Loberman-Nachum, N., Weiss, B., Leichtmann-Bardoogo, Y., Maoz, B., Denson, L., Gal-Mor, O., Vandussen, K., Amir, A. & Haberman Ziv, Y., 22 Jan 2025, In: Journal of Crohn's and Colitis. 19, p. i306-i308 3 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Long-term laboratory follow-up is essential in pediatric patients with celiac
Krauthammer, A., Guz-Mark, A., Zevit, N., Waisbourd-Zinman, O., Mozer-Glassberg, Y., Friedler, V. N., Rozenfeld Bar Lev, M., Matar, M., Shouval, D. & Shamir, R., May 2025, In: Journal of Pediatric Gastroenterology and Nutrition. 80, 5, p. 816-823 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Overcoming anti-Infliximab antibodies and maintaining Infliximab achieves superior durability and outcome compared to switching to Adalimumab
Granot, M., Nachum, N., Krauthammer, A., Berger, T. D., Heiman, S., Yavzori, M., Picard, O., Ben-Horin, S., Weiss, B. & Haberman, Y., Nov 2025, In: Digestive and Liver Disease. 57, 11, p. 2128-2134 7 p.Research output: Contribution to journal › Article › peer-review